BUSINESS Supriya Lifescience receives positive US FDA inspection report with minor observation Apr 22, 2026
CORPORATES Supriya Lifescience’s Ambernath facility receives WHO-GMP certification for Inhalation Dosages Oct 1, 2025
STOCK MARKET Supriya Lifescience shares surge 2% after inauguration of new API production facility Dec 18, 2024
Supriya Lifescience inaugurates Rs 125 crore Module E production block at Lote Parshuram, boosts capacity by 55% Dec 17, 2024
Supriya Lifescience strengthens global presence with Brazil approval and atorvastatin patent filing Dec 9, 2024